Evidence map›Paper›PMID 32409672›Full record

ArticleScientific reports2020

Aging with Toxoplasma gondii results in pathogen clearance, resolution of inflammation, and minimal consequences to learning and memory.

Kathryn E McGovern, Carla M Cabral, Helena W Morrison, Anita A Koshy

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. iScience · 2026
    Article
  3. Review
  4. Toxoplasma gondii and the Brain: Frenemies? Or Just Outright Foes?Journal of the Pediatric Infectious Diseases Society · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Injection witheLife · 2021
    Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kathryn E McGovernBIO5 Institute, University of Arizona, Tucson, Arizona, United States.
Carla M CabralBIO5 Institute, University of Arizona, Tucson, Arizona, United States.
Helena W MorrisonCollege of Nursing, University of Arizona, Tucson, Arizona, United States.
Anita A KoshyBIO5 Institute, University of Arizona, Tucson, Arizona, United States. akoshy@email.arizona.edu.
University of Arizona · US

Funding

Postdoctoral Training, Neurobiology of Aging and Alzheimer's DiseaseT32AG044402 · NIA · UNIVERSITY OF ARIZONA · PI CAROL A. BARNES · 2016 to 2026
$1.8M
Toxoplasma Gondii-Associated Protection Against CNS Amyloid: Mechanisms and ImplicationsR21AG056894 · NIA · UNIVERSITY OF ARIZONA · PI KOSHY, ANITA · 2018 to 2019
$413k
Neuroinflammation as a Theraputic Avenue for Alzheimer's Disease TreatmentF32AG058440 · NIA · UNIVERSITY OF ARIZONA · PI MCGOVERN, KATHRYN ELIZABETH · 2017 to 2020
$141k
NIA NIH HHS F32 AG058440NIA NIH HHS R21 AG056894NIA NIH HHS T32 AG044402
6 · The paper itself

Abstract

Persistent inflammation has been identified as a contributor to aging-related neurodegenerative disorders such as Alzheimer's disease. Normal aging, in the absence of dementia, also results in gradual cognitive decline and is thought to arise, in part, because of a chronic pro-inflammatory state in the brain. Toxoplasma gondii is an obligate intracellular parasite that establishes a persistent, asymptomatic infection of the central nervous system (CNS) accompanied by a pro-inflammatory immune response in many of its hosts, including humans and rodents. Several studies have suggested that the inflammation generated by certain strains of T. gondii infection can be neuroprotective in the context of a secondary insult like beta-amyloid accumulation or stroke. Given these neuroprotective studies, we hypothesized that a prolonged infection with T. gondii may protect against age-associated decline in cognition. To test this hypothesis, we infected young adult mice with either of two genetically distinct, persistent T. gondii strains (Prugniaud/type II/haplogroup 2 and CEP/type III/haplogroup 3) and monitored mouse weight, survival, and learning and memory over the ensuing 20 months. At the end of the study, we evaluated CNS inflammation and parasite burden in the surviving mice. We found that parasite infection had no impact on age-associated decline in learning and memory and that by 20 months post infection, in the surviving mice, we found no evidence of parasite DNA, cysts, or inflammation in the CNS. In addition, we found that mice infected with type III parasites, which are supposed to be less virulent than the type II parasites, had a lower rate of long-term survival. Collectively, these data indicate that T. gondii may not cause a life-long CNS infection. Rather, parasites are likely slowly cleared from the CNS and infection and parasite clearance neither positively nor negatively impacts learning and memory in aging.

Indexed as

AgingHost-Parasite InteractionsLearningMemoryAnimalsBrainDisease Models, AnimalHumansMiceMyeloid CellsT-LymphocytesToxoplasmaToxoplasmosisVirulence

Identifiers

PMID32409672
PMCPMC7224383
OpenAlexW3024173601

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.